Cite

HARVARD Citation

    Busch, A. et al. (n.d.). Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients. Clinical and experimental immunology. pp. 439-453. [Online]. 
  
Back to record